 <h1>Terazol 7 Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>terconazole topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about terconazole topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Terazol 7.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to terconazole topical: vaginal cream, vaginal suppository</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, terconazole topical (the active ingredient contained in Terazol 7) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking terconazole topical:</p><p>
<i>More common</i>
</p><ul>
<li>Burning feeling in the vagina</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Chills</li>
<li>fever</li>
<li>itching or irritation in the vagina</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>chills</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>hives or welts</li>
<li>hoarseness</li>
<li>irritation</li>
<li>itching</li>
<li>joint or muscle pain</li>
<li>joint pain, stiffness or swelling</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>rash</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>redness of the skin</li>
<li>runny nose</li>
<li>shivering</li>
<li>skin rash</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>sweating</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>trouble sleeping</li>
<li>troubled breathing</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of terconazole topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Cramps</li>
<li>headache</li>
<li>heavy bleeding</li>
<li>pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>body pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Difficulty with moving</li>
<li>lack or loss of strength</li>
<li>muscle aching or cramping</li>
<li>muscle pain or stiffness</li>
<li>swollen joints</li>
</ul><p>
<!-- end vaginal cream, vaginal suppository --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to terconazole topical: vaginal cream, vaginal suppository</i></p><h3>Nervous system</h3><p>Headache was reported in 26%, 21%, and 30.3% of patients using the 0.4% vaginal cream, 0.8% vaginal cream, and vaginal suppositories, respectively.  In clinical trials with the suppository, headache occurred in up to 20.7% of patients given placebo.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Headache (up to 30.3%)</p>
<p><b>Postmarketing reports</b>: Dizziness<sup>[Ref]</sup></p><h3>Local</h3><p>The suppository formulation was discontinued most often due to burning and pruritus.<sup>[Ref]</sup></p><p>Frequency nor reported: Pain, rash</p>
<p></p>
<p>Vaginal suppositories:</p>
<p>-Very common (10% or more): Burning (15.2%)</p>
<p>-Common (1% to 10%): Pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>The cream formulations were discontinued most often due to vulvovaginal itching.<sup>[Ref]</sup></p><p>Vaginal cream 0.4%:</p>
<p>-Frequency not reported: Vulvovaginal burning/itching/irritation</p>
<p></p>
<p>Vaginal cream 0.8%:</p>
<p>-Common (1% to 10%): Dysmenorrhea, genital burning and itching</p>
<p>-Frequency not reported: Vulvovaginal itching</p>
<p></p>
<p>Vaginal suppositories:</p>
<p>-Common (1% to 10%): Pain of the female genitalia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Influenza-like illness (consisting of fever, chills, nausea, dizziness)</p>
<p><b>Postmarketing reports</b>: Asthenia, influenza-like illness (consisting of multiple reactions including fever, chills, nausea, vomiting, myalgia, arthralgia, malaise), face edema</p>
<p></p>
<p>Vaginal cream 0.4%</p>
<p>-Common (1% to 10%): Body pain, fever</p>
<p>-Uncommon (0.1% to 1%): Chills</p>
<p></p>
<p>Vaginal cream 0.8%</p>
<p>-Uncommon (0.1% to 1%): Fever</p>
<p></p>
<p>Vaginal suppositories</p>
<p>-Common (1% to 10%): Body pain, fever, chills<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Vaginal cream 0.8%:</p>
<p>-Common (1% to 10%): Abdominal pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity, anaphylaxis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Photosensitivity reactions were reported after repeated dermal application of 2% and 0.8% cream formulations under conditions of filtered artificial ultraviolet light.  During US and foreign clinical trials, photosensitivity reactions were not reported in patients who were treated with the suppositories or vaginal cream (0.4% and 0.8%).<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Photosensitivity reactions</p>
<p><b>Postmarketing reports</b>: Rash, toxic epidermal necrolysis, urticaria<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea</p>
<p><b>Postmarketing reports</b>: Bronchospasm<sup>[Ref]</sup></p><p>At least 1 patient developed leukocytosis and dyspnea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>At least 1 patient developed leukocytosis and dyspnea.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Leukocytosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Terazol 3 (terconazole)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Terazol 7 (terconazole topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: vaginal anti-infectives</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Terazol 7 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Terazol 3, Zazole</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Terazol</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Vaginal Yeast Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to terconazole topical: vaginal cream, vaginal suppository</i></p><h3>Nervous system</h3><p>Headache was reported in 26%, 21%, and 30.3% of patients using the 0.4% vaginal cream, 0.8% vaginal cream, and vaginal suppositories, respectively.  In clinical trials with the suppository, headache occurred in up to 20.7% of patients given placebo.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Headache (up to 30.3%)</p><p><b>Postmarketing reports</b>: Dizziness<sup>[Ref]</sup></p><h3>Local</h3><p>The suppository formulation was discontinued most often due to burning and pruritus.<sup>[Ref]</sup></p><p>Frequency nor reported: Pain, rash</p><p></p><p>Vaginal suppositories:</p><p>-Very common (10% or more): Burning (15.2%)</p><p>-Common (1% to 10%): Pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>The cream formulations were discontinued most often due to vulvovaginal itching.<sup>[Ref]</sup></p><p>Vaginal cream 0.4%:</p><p>-Frequency not reported: Vulvovaginal burning/itching/irritation</p><p></p><p>Vaginal cream 0.8%:</p><p>-Common (1% to 10%): Dysmenorrhea, genital burning and itching</p><p>-Frequency not reported: Vulvovaginal itching</p><p></p><p>Vaginal suppositories:</p><p>-Common (1% to 10%): Pain of the female genitalia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Influenza-like illness (consisting of fever, chills, nausea, dizziness)</p><p><b>Postmarketing reports</b>: Asthenia, influenza-like illness (consisting of multiple reactions including fever, chills, nausea, vomiting, myalgia, arthralgia, malaise), face edema</p><p></p><p>Vaginal cream 0.4%</p><p>-Common (1% to 10%): Body pain, fever</p><p>-Uncommon (0.1% to 1%): Chills</p><p></p><p>Vaginal cream 0.8%</p><p>-Uncommon (0.1% to 1%): Fever</p><p></p><p>Vaginal suppositories</p><p>-Common (1% to 10%): Body pain, fever, chills<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Vaginal cream 0.8%:</p><p>-Common (1% to 10%): Abdominal pain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity, anaphylaxis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Photosensitivity reactions were reported after repeated dermal application of 2% and 0.8% cream formulations under conditions of filtered artificial ultraviolet light.  During US and foreign clinical trials, photosensitivity reactions were not reported in patients who were treated with the suppositories or vaginal cream (0.4% and 0.8%).<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Photosensitivity reactions</p><p><b>Postmarketing reports</b>: Rash, toxic epidermal necrolysis, urticaria<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Dyspnea</p><p><b>Postmarketing reports</b>: Bronchospasm<sup>[Ref]</sup></p><p>At least 1 patient developed leukocytosis and dyspnea.<sup>[Ref]</sup></p><h3>Hematologic</h3><p>At least 1 patient developed leukocytosis and dyspnea.<sup>[Ref]</sup></p><p><b>Frequency not reported</b>: Leukocytosis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Terazol 3 (terconazole)." Ortho Pharmaceutical Corporation, Raritan, NJ. </p><h2>More about Terazol 7 (terconazole topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>En Español</li>
<li>3 Reviews</li>
<li>Drug class: vaginal anti-infectives</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Terazol 7 &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Terazol</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Vaginal Yeast Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>